Caricamento...

Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure

OBJECTIVES: Telavancin is approved in Europe for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus when other alternatives are not suitable. The approved European prescribing information contraindicates the use of telavancin in patients with severe renal imp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Torres, A., Rubinstein, E., Corey, G. R., Stryjewski, M. E., Barriere, S. L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023300/
https://ncbi.nlm.nih.gov/pubmed/24398339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkt490
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !